Search

Search Results

• 

  Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

  M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni

  17-03-2014 Pages 278-285

  DOI https://doi.org/10.4081/reumatismo.2013.682

  • 3,236 abstract views
  • 1,546 PDF
• 

  Primary Sjögren syndrome: report of a 10 years old girl with local edema and positivity of anti SS-A and anti SS-B autoantibodies

  E. Shahi, C. Donati, M. Gattinara, I. Pontikaki, V. Gerloni

  Pages 97-100

  DOI https://doi.org/10.4081/reumatismo.2011.97

  • 1,808 abstract views
  • 1,095 PDF

• Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the litterature and personal experience

  V. Gerloni, I. Pontikaki, M Gattinara, F. Fantini

  Pages 244-261

  DOI https://doi.org/10.4081/reumatismo.2007.244

  • 1,588 abstract views
  • 1,309 PDF

• Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy

  G. De Marco, V. Gerloni, I. Pontikaki, A. Lurati, B. Teruzzi, A. Salmaso, E. Valcamonica, M. Gattinara, F. Fantini

  Pages 50-56

  DOI https://doi.org/10.4081/reumatismo.2007.50

  • 1,396 abstract views
  • 983 PDF

• Side effects of anti-TNFa therapy in juvenile idiopathic arthritis

  Irene Pontikaki, Valeria Gerloni, Maurizio Gattinara, Alfredomaria Lurati, Alessandra Salmaso, Gabriele De Marco, Barbara Teruzzi, Elisabetta Valcamonica, Flavio Fantini

  Pages 31-38

  DOI https://doi.org/10.4081/reumatismo.2006.31

  • 2,031 abstract views
  • 2,699 PDF